11-128891437-C-G

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP4_StrongBP6

The NM_000890.5(KCNJ5):​c.-295C>G variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. There is a variant allele frequency bias in the population database for this variant (GnomAd4), which may indicate mosaicism or somatic mutations in the reference population data. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.23 ( 2300 hom., cov: 10)
Exomes 𝑓: 0.0 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

KCNJ5
NM_000890.5 5_prime_UTR

Scores

2

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: -0.917

Publications

1 publications found
Variant links:
Genes affected
KCNJ5 (HGNC:6266): (potassium inwardly rectifying channel subfamily J member 5) This gene encodes an integral membrane protein which belongs to one of seven subfamilies of inward-rectifier potassium channel proteins called potassium channel subfamily J. The encoded protein is a subunit of the potassium channel which is homotetrameric. It is controlled by G-proteins and has a greater tendency to allow potassium to flow into a cell rather than out of a cell. Naturally occurring mutations in this gene are associated with aldosterone-producing adenomas. [provided by RefSeq, Aug 2017]
KCNJ5-AS1 (HGNC:28584): (KCNJ5 antisense RNA 1) Predicted to be located in extracellular region. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.21).
BP6
Variant 11-128891437-C-G is Benign according to our data. Variant chr11-128891437-C-G is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 303601.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNJ5NM_000890.5 linkc.-295C>G 5_prime_UTR_variant Exon 1 of 3 ENST00000529694.6 NP_000881.3 P48544A0A5J6E2W8
KCNJ5NM_001354169.2 linkc.-384C>G 5_prime_UTR_variant Exon 1 of 4 NP_001341098.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNJ5ENST00000529694.6 linkc.-295C>G 5_prime_UTR_variant Exon 1 of 3 1 NM_000890.5 ENSP00000433295.1 P48544
KCNJ5-AS1ENST00000730925.1 linkn.314+12994G>C intron_variant Intron 2 of 2
KCNJ5-AS1ENST00000730926.1 linkn.285+12994G>C intron_variant Intron 2 of 2
KCNJ5ENST00000338350.4 linkc.-384C>G upstream_gene_variant 1 ENSP00000339960.4 P48544

Frequencies

GnomAD3 genomes
AF:
0.228
AC:
15807
AN:
69348
Hom.:
2293
Cov.:
10
show subpopulations
Gnomad AFR
AF:
0.367
Gnomad AMI
AF:
0.278
Gnomad AMR
AF:
0.186
Gnomad ASJ
AF:
0.343
Gnomad EAS
AF:
0.152
Gnomad SAS
AF:
0.158
Gnomad FIN
AF:
0.112
Gnomad MID
AF:
0.164
Gnomad NFE
AF:
0.193
Gnomad OTH
AF:
0.233
GnomAD4 exome
Data not reliable, filtered out with message: AC0;AS_VQSR
AF:
0.00
AC:
0
AN:
256
Hom.:
0
Cov.:
0
AF XY:
0.00
AC XY:
0
AN XY:
202
African (AFR)
AC:
0
AN:
0
American (AMR)
AC:
0
AN:
0
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2
East Asian (EAS)
AF:
0.00
AC:
0
AN:
6
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
2
Middle Eastern (MID)
AC:
0
AN:
0
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
234
Other (OTH)
AF:
0.00
AC:
0
AN:
10
GnomAD4 genome
AF:
0.228
AC:
15810
AN:
69344
Hom.:
2300
Cov.:
10
AF XY:
0.220
AC XY:
7161
AN XY:
32494
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.368
AC:
5550
AN:
15102
American (AMR)
AF:
0.185
AC:
1251
AN:
6754
Ashkenazi Jewish (ASJ)
AF:
0.343
AC:
583
AN:
1702
East Asian (EAS)
AF:
0.152
AC:
339
AN:
2234
South Asian (SAS)
AF:
0.159
AC:
239
AN:
1506
European-Finnish (FIN)
AF:
0.112
AC:
464
AN:
4140
Middle Eastern (MID)
AF:
0.148
AC:
16
AN:
108
European-Non Finnish (NFE)
AF:
0.193
AC:
7070
AN:
36582
Other (OTH)
AF:
0.231
AC:
200
AN:
864
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.388
Heterozygous variant carriers
0
548
1096
1645
2193
2741
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
138
276
414
552
690
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0574
Hom.:
83

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:1
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Familial hyperaldosteronism type III Uncertain:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. -

Congenital long QT syndrome Uncertain:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 12, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.2
CADD
Benign
3.0
DANN
Benign
0.36
PhyloP100
-0.92
PromoterAI
0.047
Neutral
Mutation Taster
=299/1
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs372328307; hg19: chr11-128761332; COSMIC: COSV57965279; COSMIC: COSV57965279; API